Teen Beats Stage 4 Cancer with New FDA-Approved Treatment

Leah Pshedesky was supposed to be preparing for junior year when doctors found a tumor pressing against her windpipe and heart.

The diagnosis was Stage 4 Hodgkin lymphoma. For most families, those words would signal months of grueling treatment ahead.

But Leah became one of the first pediatric patients to benefit from Nivolumab, an immunotherapy the FDA recently approved for patients 12 and older. The medication had already shown remarkable results in adults.

"It's an antibody agent that harnesses a patient's own immune system," explained Dr. Brian Guedes, Leah's oncologist at Johns Hopkins All Children's Hospital in St. Petersburg. Traditional chemotherapy attacks cancer cells directly, but this treatment teaches the body to fight back on its own.

The approach delivered more than just a cure. It spared Leah from the brutal side effects that often come with conventional treatment.

"We are sparing patients from more exposure to traditional chemotherapy medications, which carry lots of kidney or liver damage or infertility," Dr. Guedes said. Leah's response was so strong she didn't even need radiation.

Today, the now high school senior is completely cancer-free and making college plans. She's channeling the emotional whirlwind of her diagnosis into something beautiful: her music.

"Being able to channel those feelings into my music, being able to use the emotions from the diagnosis and the shock," said Leah, who plays piano and bassoon. "It was insanity being able to put that out."

Why This Inspires

Leah's story shows how far cancer treatment has come, especially for young patients who deserve long, healthy lives ahead. The approval of Nivolumab for pediatric use means thousands more kids will have access to gentler, more effective treatment options. Her parents watched their daughter face the unimaginable with grace, and now they get to watch her thrive.

"I can't wait to see what the future holds for her," her mother, Saralynne Pshedesky, said.

Leah is ready to stop worrying about cancer and start living the normal teenage life she deserves.